StonvexLoading…
StonvexStonvexStonvexCore line items from AMTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $197.63M | $267.64M | $186.72M | $256.51M |
Operating Income | $-37.22M | $-40.42M | $-37.40M | $-34.40M |
Net Income | $-77.00M | $-87.54M | $-46.42M | $-107.76M |
EPS (Diluted) | $-1.28 | $-1.91 | $-1.22 | $-3.12 |
Total Assets | $259.84M | $259.30M | $243.41M | $207.11M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $4.89M | $898.00K | $2.67M | $4.31M |
Free Cash Flow OCF − CapEx | $-22.74M | $-53.18M | $-19.29M | $-62.02M |
Shares Outstanding | 66.19M | 51.14M | 40.97M | 35.87M |